Resultados da busca - Fabio A. Schutz

  • Mostrando 1 - 11 resultados de 11
Refinar Resultados
  1. 1
    Treatment Patterns Among Patients With Advanced Prostate Cancer in Brazil: An Analysis of a Private Healthcare System Database

    Treatment Patterns Among Patients With Advanced Prostate Cancer in Brazil: An Analysis of a Private Healthcare System Database por Mariane Fontes, Fabio A. Schutz, Murilo Luz, Giovanni Bomfim, Luciana Tarbes Mattana Saturnino, Sarah Carolina Goncalves, Roberto Soler

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  2. 2
    Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy

    Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after... por Joaquim Bellmunt, Ronan Fougeray, Jacob Rosenberg, Hans von der Maase, Fabio A. Schutz, Yacine Salhi, Stéphane Culine, Toni K. Choueiri

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  3. 3
    Incidence and risk of treatment-related mortality in cancer patients treated with the mammalian target of rapamycin inhibitors

    Incidence and risk of treatment-related mortality in cancer patients treated with the mammalian target of rapamycin inhibitors por Toni K. Choueiri, Youjin Je, Guru Sonpavde, Christopher J. Richards, Matthew D. Galsky, Paul L. Nguyen, Fabio A. Schutz, D.Y.C. Heng, Marina D. Kaymakcalan

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  4. 4
    Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study

    Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study por Fabio A. Schutz, Mark M. Pomerantz, Kathryn P. Gray, Michael B. Atkins, Jonathan E. Rosenberg, Michelle S. Hirsch, David F. McDermott, Megan E. Lampron, Gwo‐Shu Mary Lee, Sabina Signoretti, Philip W. Kantoff, Matthew L. Freedman, Toni K. Choueiri

    Publicado em 2012
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  5. 5
    Non-metastatic castration-resistant prostate cancer (nmCRPC): Meta-analysis of efficacy and safety with novel hormonal agents apalutamide and enzalutamide

    Non-metastatic castration-resistant prostate cancer (nmCRPC): Meta-analysis of efficacy and safety with novel hormonal agents apalutamide and enzalutamide por Daniel Vargas Pivato de Almeida, Cleyton Zanardo de Oliveira, Rodrigo Mariano, Fabio Kater, M.C.L.A. Souza, Viviane C. Ruiz-Schutz, Rosely Yamamura, Ricardo Saraiva de Carvalho, Fernando Cotait Maluf, Alicia K. Morgans, S. Srinivas, Shilpa Gupta, Tanya B. Dorff, Evan Y. Yu, Fabio A. Schutz

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  6. 6
    LBA8 Phase III study of cabozantinib (C) in combination with nivolumab (N) and ipilimumab (I) in previously untreated advanced renal cell carcinoma (aRCC) of IMDC intermediate or poor risk (COSMIC-313)

    LBA8 Phase III study of cabozantinib (C) in combination with nivolumab (N) and ipilimumab (I) in previously untreated advanced renal cell carcinoma (aRCC) of IMDC intermediate or p... por Toni K. Choueiri, Tom Powles, Laurence Albigès, M. Burotto, C. Szczylik, B. Zurawski, E. Yanez Riuz, Marco Maruzzo, Alberto Suárez Zaizar, Luis Fein, Fabio A. Schutz, Daniel Yick Chin Heng, F. Wang, Fabio Mataveli, Yih‐Leong Chang, Maximiliano van Kooten Losio, C. Suárez Rodríguez, Robert J. Motzer

    Publicado em 2022
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  7. 7
    Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma

    Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma por Toni K. Choueiri, Thomas Powles, Laurence Albigès, Mauricio Burotto, Cezary Szczylik, Bogdan Żurawski, Eduardo Yañez Ruiz, Marco Maruzzo, Alberto Suárez Zaizar, Luis Fein, Fabio A. Schutz, Daniel Y.C. Heng, Fong Wang, Fabio Mataveli, Yu-Lin Chang, Maximiliano van Kooten Losio, Cristina Suárez, Robert J. Motzer

    Publicado em 2023
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  8. 8
    First brazilian consensus of advanced prostate cancer: recommendations for clinical practice

    First brazilian consensus of advanced prostate cancer: recommendations for clinical practice por André Deeke Sasse, Evanius Garcia Wiermann, Daniel Herchenhorn, Diogo Assed Bastos, Fabio A. Schutz, Fernando Cotait Maluf, George Barbério Coura-Filho, Igor Alexandre Protzner Morbeck, Juliano J. Cerci, Òren Smaletz, Volney Soares Lima, Ari Adamy, Franz Campos, Gustavo Franco Carvalhal, Leandro Casemiro Cezar, Marcos F. Dall’Oglio, Marcus Vinícius Sadi, Rodolfo Borges dos Reis, Lucas Nogueira

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  9. 9
    Consensus on Treatment and Follow-Up for Biochemical Recurrence in Castration-Sensitive Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries

    Consensus on Treatment and Follow-Up for Biochemical Recurrence in Castration-Sensitive Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Dev... por Fernando Sabino Marques Monteiro, Fabio A. Schutz, Igor Alexandre Protzner Morbeck, Diogo Assed Bastos, Fernando Vidigal Pádua, L. Costa, Manuel Caitano Maia, José Augusto Rinck, Stênio de Cássio Zéqui, Karine Martins da Trindade, Wladimir Alfer, William C. Nahas, Lucas Vieira dos Santos, Robson Ferrigno, Diogo Augusto Rodrigues da Rosa, Juan Pablo Sade, Francisco J. Orlandi, Fernando Nunes Galvão de Oliveira, Andrey Soares

    Publicado em 2021
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  10. 10
    A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels (LACOG 0415)

    A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone le... por Fernando Cotait Maluf, Fabio A. Schutz, Eduardo Cronemberger, Murilo Luz, Suelen P. S. Martins, David Q.B. Muniz, Diogo Assed Bastos, Flavio Mavignier Cárcano, Òren Smaletz, Andrey Soares, Fábio Affonso Peixoto, Andrea Juliana Gomes, Felipe Melo Cruz, Fábio Franke, Daniel Herchenhorn, Telma Santos, Vanessa de Carvalho Fabrício, Rosemarie Gidekel, Gustavo Werutsky, Rafaela Gomes de Jesus, Vinícius Carrera Souza, André P. Fay

    Publicado em 2021
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  11. 11
    Multicenter Database of Patients with Germ-Cell Tumors: A Latin American Cooperative Oncology Group Registry (LACOG 0515)

    Multicenter Database of Patients with Germ-Cell Tumors: A Latin American Cooperative Oncology Group Registry (LACOG 0515) por Diogo Assed Bastos, Aline Bobato Lara Gongora, Carlos Dzik, Denis L. Jardim, Marina Piva, Flavio Mavignier Cárcano, Glaucio Bertollo, Karine Martins da Trindade, Mariane Fontes, Andrey Soares, Tomás Reinert, Rita de Cássia Costamilan, Rodrigo U. Villarroel, Gabriel Watarai, Antonia Angeli Gazola, Daniel D’Almeida Preto, Haila Mutti, Marcela Bonalumi dos Santos, Rodrigo Mariano, Monique Binotto, Monique Maciel Carvalho, Veronica Patrícia da Costa Oliveira, Rafaela Gomes de Jesus, Taiane Francieli Rebelatto, Fabio A. Schutz, Òren Smaletz, André P. Fay

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: